LKB1‐SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibitionSarah Proteau, Thomas Strub, Imène Krossa et al.|EMBO Molecular Medicine|2023Cited by 16
Ontogeny Dictates Oncogenic Potential, Lineage Hierarchy, and Therapy Response in Pediatric LeukemiaIan G. Phelps, Dan Filipescu, Mirela Berisa et al.|Cancer Discovery|2025Cited by 2
Table S1 from Ontogeny Dictates Oncogenic Potential, Lineage Hierarchy, and Therapy Response in Pediatric LeukemiaKe Wang, Eric Y. So, Shayan Saniei et al.|Unknown|2026Cited by 0
Figure S2 from Ontogeny Dictates Oncogenic Potential, Lineage Hierarchy, and Therapy Response in Pediatric LeukemiaKe Wang, Eric Y. So, Shayan Saniei et al.|Unknown|2026Cited by 0
Table S6 from Ontogeny Dictates Oncogenic Potential, Lineage Hierarchy, and Therapy Response in Pediatric LeukemiaKe Wang, Eric Y. So, Shayan Saniei et al.|Unknown|2026Cited by 0